Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease

Background: There are limited data for non-vitamin K antagonist oral anticoagulants (NOACs) impact on outcomes for patients with atrial fibrillation (AF) and valvular heart diseases (VHDs). Methods: We identified patients with AF and associated Evaluated Heartvalves, Rheumatic or Artificial (EHRA) t...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Inki, Lee, So-Ryoung, Choi, Eue-Keun, Lee, Euijae, Jung, Jin-Hyung, Han, Kyung-Do, Cha, Myung-Jin, Oh, Seil, Lip, Gregory Y.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832302/
https://www.ncbi.nlm.nih.gov/pubmed/31590290
http://dx.doi.org/10.3390/jcm8101624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832302/
https://www.ncbi.nlm.nih.gov/pubmed/31590290
http://dx.doi.org/10.3390/jcm8101624

Ejemplares similares